Paul A Heidenreich
Biographic Data
| ID | 5539695 |
|---|---|
| NAME | Paul A Heidenreich |
| GIVEN NAMES | Paul A |
| FAMILY NAME | Heidenreich |
| SIGNATURE | HEIDENREICH P A |
| AFFILIATIONS | Stanford University |
| ORCID | 0000-0001-7730-8490 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Interventions to Increase Leukocyte Testing during Treatment with Dimethyl Fumarate
Dimethyl fumarate (DMF), a treatment for multiple sclerosis, may cause leukopenia and infection. Accordingly, periodic white blood cell (WBC) monitoring is recommended. We sought to evaluate the US Department of Veteran Affairs' safety program which provides facilities with a list of patients prescribed DMF therapy without a documented white blood cell count (WBC). We identified 118 sites with patients treated with DMF from 1 January 2016 through…
Reasons for Not Prescribing Guideline-recommended Medications to Adults With Heart Failure
BACKGROUND: Little is known about how often contextual factors such as patient preferences and competing priorities impact prescribing of guideline-recommended medications, or about the extent to which these factors are documented in medical records and available to performance measurement systems. METHODS: Mixed-methods study of 295 veterans aged 50 years and older in 4 VA health care systems who had systolic heart failure and were not prescribe…
Forecasting the Future of Cardiovascular Disease in the United States
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death in the United States and is responsible for 17% of national health expenditures. As the population ages, these costs are expected to increase substantially. METHODS AND RESULTS: To prepare for future cardiovascular care needs, the American Heart Association developed methodology to project future costs of care for hypertension, coronary heart disease, heart failure, stroke, an…
No prominent works on this page.
Forecasting the Future of Cardiovascular Disease in the United States
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death in the United States and is responsible for 17% of national health expenditures. As the population ages, these costs are expected to increase substantially. METHODS AND RESULTS: To prepare for future cardiovascular care needs, the American Heart Association developed methodology to project future costs of care for hypertension, coronary heart disease, heart failure, stroke, an…
Reasons for Not Prescribing Guideline-recommended Medications to Adults With Heart Failure
BACKGROUND: Little is known about how often contextual factors such as patient preferences and competing priorities impact prescribing of guideline-recommended medications, or about the extent to which these factors are documented in medical records and available to performance measurement systems. METHODS: Mixed-methods study of 295 veterans aged 50 years and older in 4 VA health care systems who had systolic heart failure and were not prescribe…
Interventions to Increase Leukocyte Testing during Treatment with Dimethyl Fumarate
Dimethyl fumarate (DMF), a treatment for multiple sclerosis, may cause leukopenia and infection. Accordingly, periodic white blood cell (WBC) monitoring is recommended. We sought to evaluate the US Department of Veteran Affairs' safety program which provides facilities with a list of patients prescribed DMF therapy without a documented white blood cell count (WBC). We identified 118 sites with patients treated with DMF from 1 January 2016 through…
Medicine (3 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Angiotensin Receptor Blockers (1 work) · Angiotensin-converting enzyme (1 work) · Blood pressure (1 work) · Blood Pressure and Hypertension Studies (1 work) · Cardiovascular Health and Risk Factors (1 work) · Chronic Disease Management Strategies (1 work) · Context (archaeology) (1 work)